Bas Molenaar
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiomyopathy and Myosin Studies
-
- Congenital heart defects research
- Single-cell and spatial transcriptomics
- Signaling Pathways in Disease
- CRISPR and Genetic Engineering
- RNA modifications and cancer
Papers in
-
- Cardiac Fibrosis and Remodeling 4
- Cardiomyopathy and Myosin Studies 2
- Cardiovascular Effects of Exercise 1
-
- Congenital heart defects research 3
- Signaling Pathways in Disease 2
- Single-cell and spatial transcriptomics 2
- CRISPR and Genetic Engineering 1
- Co-authors
- Eva van Rooij (10 shared papers)Daniëlle Versteeg (8 shared papers)Monika M Gladka (7 shared papers)Hesther de Ruiter (4 shared papers)Manon M. H. Huibers (3 shared papers)Grégory Lacraz (2 shared papers)Alexander van Oudenaarden (2 shared papers)Stefan van der Elst (1 shared paper)
- Journals
- Cancer Cell (2 papers)Cardiovascular Research (2 papers)Circulation (2 papers)Science Translational Medicine (1 paper)European Heart Journal (1 paper)
- Partner nations
- NetherlandsItalyBelgium
In The Last Decade
Bas Molenaar
12 papers receiving 697 citations
Peers
Comparison fields: 5 of 64
- Cardiology and Cardiovascular Medicine 242
- Molecular Biology 449
- Business and International Management 9
- Cancer Research 58
- Aging 5
Countries citing papers authored by Bas Molenaar
This map shows the geographic impact of Bas Molenaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas Molenaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas Molenaar more than expected).
Fields of papers citing papers by Bas Molenaar
This network shows the impact of papers produced by Bas Molenaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas Molenaar. The network helps show where Bas Molenaar may publish in the future.
Co-authors
The 25 scholars most cited alongside Bas Molenaar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 250 | |
| 2 | 2017 | 87 | |
| 3 | 2021 | 80 | |
| 4 | 2021 | 57 | |
| 5 | 2017 | 54 | |
| 6 | 2016 | 48 | |
| 7 | 2022 | 40 | |
| 8 | 2002 | 31 | |
| 9 | 2021 | 28 | |
| 10 | 2022 | 15 | |
| 11 | 2016 | 5 | |
| 12 | 2024 | 4 | |
| 13 | 2020 | 0 |
About Bas Molenaar
Bas Molenaar is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Neurology, Cancer Research and Cell Biology, having authored 13 papers that have together received 699 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (4 papers), Congenital heart defects research (3 papers), Neuroblastoma Research and Treatments (2 papers), Signaling Pathways in Disease (2 papers), Cardiomyopathy and Myosin Studies (2 papers), Single-cell and spatial transcriptomics (2 papers), CRISPR and Genetic Engineering (1 paper) and Cardiovascular Effects of Exercise (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (242 citations), Molecular Biology (449 citations), Business and International Management (9 citations), Cancer Research (58 citations) and Aging (5 citations). Bas Molenaar has collaborated with scholars based in Netherlands, Italy and Belgium. Frequent co-authors include Eva van Rooij, Daniëlle Versteeg, Monika M Gladka, Hesther de Ruiter, Manon M. H. Huibers, Grégory Lacraz, Alexander van Oudenaarden, Stefan van der Elst, Hoyee Tsui and Lieneke Kooijman. Their work appears in journals such as Cancer Cell, Cardiovascular Research, Circulation, Science Translational Medicine and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.